FDA Approves Duramed's Synthetic Conjugated Estrogens-A Vaginal Cream
 

Barr Pharmaceuticals, Inc. (NYSE:BRL) today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for Synthetic Conjugated Estrogens-A (SCE-A) 0.625 mg/g Vaginal Cream.

More...